Data de publicação: 14/11/2024 - 10:43
An article published in the journal The Lancet Infectious Diseases points to the importance of anticipating rapid responses to the risks of vertical transmission (from mother to fetus) of the Oropouche virus, considering the experience of almost a decade of research into the congenital syndrome associated with Zika virus infection. The text, authored by experts from the Zika Brazilian Cohorts (ZBC) Consortium, which includes Fiocruz Bahia...
Notícias
Data de publicação: 13/11/2024 - 13:59
The consumption of alcoholic beverages represented a cost to Brazil of around R$18.8 billion (US$ 3.27 billion) in 2019. This is the conclusion of the study Estimação dos custos diretos e indiretos atribuíveis ao consumo do álcool no Brasil [Estimating the direct and indirect costs attributable to alcohol consumption in Brazil], carried out by Fiocruz Brasília under the leadership of researcher Eduardo Nilson...
Notícias
Data de publicação: 13/11/2024 - 09:42
A study published in the New England Journal of Medicine confirms the vertical transmission of the Oropouche virus in a case of fetal death recorded in Ceará. This is the third confirmed case in the country. Vertical transmission occurs when a microorganism passes from mother to baby during pregnancy. The work was carried out in collaboration with the Oswaldo Cruz Institute (IOC/Fiocruz), through the Laboratory of Arboviruses and...
Notícias
Data de publicação: 12/11/2024 - 14:47
Amid the proliferation of speeches encouraging changes in personal habits as a way of preventing cancer, an international study carried out in seven countries, including Brazil, points out that knowledge about the disease and its causes has been markedly focused on the actions of individuals and masks the contribution of global industrial capital to the incidence and prevalence of neoplasms, the second leading cause of death worldwide, according...
Notícias
Data de publicação: 12/11/2024 - 12:32
For the third consecutive year, Fiocruz News Agency (AFN), published by the Social Communication Coordination (CCS) of the Foundation's Presidency, was honored with the Einstein Most Admired in Health, Science, and Wellbeing Award, promoted by the Hospital Israelita Albert Einstein in partnership with the website Jornalistas&Cia. The award, in the category Specialized Outlet in Science Journalism, was granted on Monday (11/4) and is the...
Notícias
Data de publicação: 12/11/2024 - 11:37
It was in 2004 that the Social Communication Coordination (CCS/Fiocruz) decided to turn its website into the Fiocruz News Agency, as a natural evolution of the growth and visibility of its old web page, launched in 1998. The department had a team of experienced journalists, who were used to writing about health and science, and had a large volume of news from Fiocruz to disseminate. Until then, news agencies were linked to major newspapers (...
Notícias
Data de publicação: 08/11/2024 - 10:22
On Tuesday (10/29), the Leônidas e Maria Deane Institute (ILMD/Fiocruz Amazônia) and the Fiocruz Global Health Center (Cris/Fiocruz) accompanied the special agenda of the German minister of Health, physician and epidemiologist Karl Lauterbach, in Manaus, the day before his participation in the G20 Ministers of Health’s Meeting in Rio de Janeiro. The mission was coordinated by the director of Fiocruz Amazônia, Stefanie...
Notícias
Data de publicação: 07/11/2024 - 16:01
In the midst of the discussions of the G20 Health Working Group, taking place between October 29th and 31st in Rio de Janeiro, Brazil's minister of Health, Nísia Trindade Lima, participated in bilateral meetings with authorities and global leaders. The president of Fiocruz, Mario Moreira, was invited by the minister and accompanied her to some of these meetings, such as with the CEO of Cepi, the vice minister of Health of Japan, the...
Notícias
Data de publicação: 07/11/2024 - 14:55
The Mosaic Project, coordinated by the French Research Institute for Development (IRD), began its data collection stage in Brazil this week, starting with the Alto Solimões region in Amazonas, in the Triple Border area (Brazil/Peru/Colombia), in the group's first mission to Latin America. The aim of the project is to implement open and replicable multimodal information ecosystems on the health of populations in Brazil's border...
Notícias
Data de publicação: 01/11/2024 - 14:27
Fiocruz researchers presented work involving neglected diseases such as leprosy and malaria, as well as COVID-19, at the Annual Meeting of the Pasteur Network, which began 10/21 in Rio de Janeiro and is being held for the first time in the Americas, co-organized by the Foundation. Among the topics of the studies presented are the selection and formulation of more effective treatments and vaccines that do not yet exist in the country. These three...
Notícias
Data de publicação: 01/11/2024 - 14:18
Strengthening science and working together to tackle health challenges and promote equity in access was the main theme of the speeches on Monday (10/21) at the opening ceremony of the Pasteur Network Annual Meeting 2024 (PNAM 2024). Co-hosted by Fiocruz, the meeting runs until Thursday (10/24) in Rio de Janeiro and aims to share information between members of the Network. Opening speeches, such as those by the Brazilian Minister of Health, the...
Notícias
Data de publicação: 31/10/2024 - 14:51
The Center for Technological Development in Health (CDTS/Fiocruz) and China National Center for Bioinformation (known as CNCB) signed a memorandum of understanding (MoU) on Tuesday (10/22) for collaboration in the areas of Bioinformatics and Big Data in Biological Sciences. The document envisages not only partnerships in research and education, but also with a view to tackling national, regional and global challenges.
The director...
Notícias
Data de publicação: 31/10/2024 - 14:22
The president of Fiocruz, Mario Moreira, sent the declaration resulting from the G20 Conference of National Public Health Institutes to the minister of Health Nísia Trindade Lima, asking for the suggested measures to be implemented. The declaration recognizes the importance of the bloc of the world's largest economies in building a healthier and more equitable world and recommends that future presidencies of the group invite the...
Notícias
Data de publicação: 25/10/2024 - 09:38
President Mario Moreira has been reelected by the public servants of Fiocruz to serve a term from 2025 to 2028 at the head of the institution. The result of the 2024 Fiocruz Election for the Presidency was announced this Thursday (October 24), following the completion of the vote counting, which ended at 5 PM (Brasilia time). The candidate received 2,901 votes, which corresponds to 81.8% of the valid votes. A total of 3,546 votes were cast....
Notícias
Data de publicação: 24/10/2024 - 12:28
Key members of the Pasteur Network, including Fiocruz, through Bio-Manguinhos, the Institut Pasteur Dakar, the Institut Pasteur Korea, the Institut Pasteur (Paris), and the Institut Pasteur Tunis, have signed a strategic Memorandum of Understanding (MoU) to strengthen collaboration in vaccine research and development, part of one of the strategic pillars of the Pasteur Network. This partnership focuses on expanding mRNA vaccine production...
Notícias
Data de publicação: 22/10/2024 - 15:42
The incidence of tuberculosis has been increasing in Latin America, where the incarcerated population has nearly quadrupled since 1990. An unprecedented study conducted by Fiocruz in partnership with institutions from Argentina, Brazil, Colombia, Peru, and the United States assessed the total impact of the tuberculosis epidemic on the incarcerated population, accounting for effects beyond incarcerations – further considering transmission...
Notícias
Data de publicação: 22/10/2024 - 09:54
An unprecedented leprosy vaccine will be tested in Brazil by the Oswaldo Cruz Institute (IOC/Fiocruz). Called LepVax, the vaccine will be the first for the disease assessed in the country during clinical trials. The authorization to begin the trials was granted by the National Health Regulatory Agency (Anvisa) on Monday (10/14).
IOC/Fiocruz will lead the first clinical test of a vaccine for leprosy (photo: Gutemberg Brito)
The...
Notícias
Data de publicação: 21/10/2024 - 12:09
On October 31st, at 2pm (London), the webinar called “Preparing for the 2025 dengue season: insights from predictive models” will take place, promoted by the Vice-presidency of Education, Information and Communication of Fiocruz (VPEIC), via the Fiocruz Scientific Computing Program (PROCC) in partnership with the consortium The Global Health Network Latin America and the Caribbean (TGHN LAC), by the Zoom platform. The event will be...
Notícias
Data de publicação: 21/10/2024 - 11:03
The Pasteur Network Annual Meeting 2024 (PNAM 2024) is taking place this year for the first time in the Americas, with Fiocruz as a co-organizer. The Opening Ceremony, which can have the presence of the press, happens this Monday (October 21) at 6 PM (RIO TIME) at the Windsor Oceânico Hotel (Rua Martinho de Mesquita, 129, Barra da Tijuca, Rio). Participants will include the Fiocruz president, Mario Moreira; the president of the Pasteur...
Notícias
Data de publicação: 17/10/2024 - 16:39
Fiocruz and GEMMA Biotherapeutics (GEMMABio) announced last Tuesday (10/8) an agreement to sponsor research focused on gene therapy treatments for the Brazilian population within the scope of the Unified Health System (SUS). The ultimate goal of the international partnership with the company founded by gene therapy expert Jim Wilson is to obtain approval for gene therapy programs that will enable the country to increase the distribution of...
Notícias
Data de publicação: 17/10/2024 - 16:17
October began with yet another heatwave in Brazil, the eighth that the country has faced in 2024. High temperatures in the Southeast, drought in the North, heavy rains in the South. Different scenarios point to a growing concern: the increase and frequency of extreme events and the risks they bring to public health. Recently, the Climate and Health Observatory of the Institute for Scientific and Technological Communication and Information in...
Notícias
Data de publicação: 17/10/2024 - 15:55
A strain of the Sars-CoV-2 virus that has been spreading around the world has been detected in Brazil. The strain called XEC, which belongs to the Omicron variant, has been identified in the states of Rio de Janeiro, São Paulo and Santa Catarina. It was first detected by the Oswaldo Cruz Institute (IOC/Fiocruz) in samples from two patients living in the capital of Rio de Janeiro, diagnosed with COVID-19 in September. The identification...
Notícias
Data de publicação: 11/10/2024 - 15:36
Brazil was the 20th country certified by the World Health Organization (WHO) for the elimination of lymphatic filariasis as a public health problem and the Institute of Drug Technology (Farmanguinhos/Fiocruz) played a key role in this achievement, as the only supplier of the drug used in the treatment registered in Brazil. Diethylcarbamazine 50mg was developed by the Institute and first registered in 1996, and it has been distributed throughout...
Notícias
Data de publicação: 09/10/2024 - 10:38
A study by Fiocruz Bahia used text mining to extract unstructured data from a Long-COVID research conducted at a university hospital in São Paulo. The aim of the work is to contribute to a deeper understanding of this chronic condition and its implications for global health systems. The model developed has potential for application in other healthcare settings, supporting broader research efforts and clinical decision-making for patients...
Notícias
Data de publicação: 02/10/2024 - 16:20
Sergio Arouca National School of Public Health (ENSP/Fiocruz), through the International Cooperation Advisory and the SUS (the Brazilian national public health system) Observatory, will host an international seminar from October 3rd to 4th, 2024, to discuss the health systems of Brazil and France.
The event will focus on territorial governance and Primary Health Care, bringing together experts and researchers from both countries to share...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
